Literature DB >> 25777952

Characterization of Pharmaceuticals and Personal Care products in hospital effluent and waste water influent/effluent by direct-injection LC-MS-MS.

Tiago S Oliveira1, Mark Murphy2, Nicholas Mendola3, Virginia Wong4, Doreen Carlson5, Linda Waring5.   

Abstract

Two USEPA Regional Laboratories developed direct-injection LC/MS/MS methods to measure Pharmaceuticals and Personal Care Products (PPCPs) in water matrices. Combined, the laboratories were prepared to analyze 185 PPCPs (with 74 overlapping) belonging to more than 20 therapeutical categories with reporting limits at low part-per-trillion. In partnership with Suffolk County in NY, the laboratories conducted PPCP analysis on 72 samples belonging to 4 Water Systems (WS). Samples were collected at different stages of the WS (hospital effluents, WWTP influents/effluents) to assess PPCP relevance in hospital discharges, impact on WWTP performance and potential ecological risk posed by analytes not eliminated during treatment. Major findings include: a) acceptable accuracy between the two laboratories for most overlapping PPCPs with better agreement for higher concentrations; b) the measurement of PPCPs throughout all investigated WS with total PPCP concentrations ranging between 324 and 965 μg L(-1) for hospital effluent, 259 and 573 μg L(-1) for WWTP influent and 19 and 118 μg L(-1) for WWTP effluent; c) the variable contribution of hospital effluents to the PPCP loads into the WWTP influents (contribution ranging between 1% (WS-2) and 59% (WS-3); d) the PPCP load reduction after treatment for all WS reaching more than 95% for WS using activated sludge processes (WS-2 and WS-4), with inflow above 6500 m(3) d(-1), and having a lower percentage of hospital effluent in the WWTP influent; e) the relevance of four therapeutical categories for the PPCP load in WWTP effluents (analgesics, antidiabetics, antiepileptics and psychoanaleptics); and f) the risk quotients calculated using screening-level Predicted Non Effect Concentration indicate that WWTP effluents contain 33 PPCPs with potential medium to high ecological risk. To our knowledge no other monitoring investigation published in the scientific literature uses direct-injection methods to cover as many PPCPs and therapeutical categories in different types of WS.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Direct injection; Hospital contribution; LC-MS-MS; PPCPs; Risk assessment; Water systems

Mesh:

Substances:

Year:  2015        PMID: 25777952     DOI: 10.1016/j.scitotenv.2015.02.104

Source DB:  PubMed          Journal:  Sci Total Environ        ISSN: 0048-9697            Impact factor:   7.963


  22 in total

1.  Characterization and toxicity of hospital wastewaters in Turkey.

Authors:  Gulsum Yilmaz; Yasemin Kaya; Ilda Vergili; Z Beril Gönder; Gül Özhan; Berna Ozbek Celik; Serdar M Altinkum; Yasar Bagdatli; Andrea Boergers; Jochen Tuerk
Journal:  Environ Monit Assess       Date:  2017-01-12       Impact factor: 2.513

2.  Two-year survey of specific hospital wastewater treatment and its impact on pharmaceutical discharges.

Authors:  Laure Wiest; Teofana Chonova; Alexandre Bergé; Robert Baudot; Frédérique Bessueille-Barbier; Linda Ayouni-Derouiche; Emmanuelle Vulliet
Journal:  Environ Sci Pollut Res Int       Date:  2017-07-17       Impact factor: 4.223

3.  Distribution of six anticancer drugs and a variety of other pharmaceuticals, and their sorption onto sediments, in an urban Japanese river.

Authors:  Takashi Azuma; Natsumi Arima; Ai Tsukada; Satoru Hirami; Rie Matsuoka; Ryogo Moriwake; Hirotaka Ishiuchi; Tomomi Inoyama; Yusuke Teranishi; Misato Yamaoka; Mao Ishida; Kanae Hisamatsu; Ayami Yunoki; Yoshiki Mino
Journal:  Environ Sci Pollut Res Int       Date:  2017-06-28       Impact factor: 4.223

4.  Screening and quantification of emerging contaminants in Periyar River, Kerala (India) by using high-resolution mass spectrometry (LC-Q-ToF-MS).

Authors:  Nejumal K Khalid; Dineep Devadasan; Usha K Aravind; Charuvila T Aravindakumar
Journal:  Environ Monit Assess       Date:  2018-05-31       Impact factor: 2.513

5.  A new decentralized biological treatment process based on activated carbon targeting organic micropollutant removal from hospital wastewaters.

Authors:  Teresa Alvarino; Elena García-Sandá; Isabel Gutiérrez-Prada; Juan Lema; Francisco Omil; Sonia Suárez
Journal:  Environ Sci Pollut Res Int       Date:  2018-07-04       Impact factor: 4.223

6.  Popular pharmaceutical residues in hospital wastewater: quantification and qualification of degradation products by mass spectroscopy after treatment with membrane bioreactor.

Authors:  M Chiarello; L Minetto; S V Della Giustina; L L Beal; S Moura
Journal:  Environ Sci Pollut Res Int       Date:  2016-05-05       Impact factor: 4.223

7.  Monitoring the release of anti-inflammatory and analgesic pharmaceuticals in the receiving environment.

Authors:  Senar Aydin; Mehmet Emin Aydin; Arzu Ulvi
Journal:  Environ Sci Pollut Res Int       Date:  2019-11-19       Impact factor: 4.223

8.  Hospital wastewaters treatment: Fenton reaction vs. BDDE vs. ferrate(VI).

Authors:  Tomáš Mackuľak; Roman Grabic; Viera Špalková; Noemi Belišová; Andrea Škulcová; Ondřej Slavík; Pavel Horký; Miroslav Gál; Jan Filip; Ján Híveš; Marian Vojs; Andrea Vojs Staňová; Alžbeta Medveďová; Marián Marton; Lucia Birošová
Journal:  Environ Sci Pollut Res Int       Date:  2019-09-05       Impact factor: 4.223

9.  Pharmaceuticals and personal care products in waters: occurrence, toxicity, and risk.

Authors:  Leslie Cizmas; Virender K Sharma; Cole M Gray; Thomas J McDonald
Journal:  Environ Chem Lett       Date:  2015-08-26       Impact factor: 9.027

10.  Microbial biotransformation of furosemide for environmental risk assessment: identification of metabolites and toxicological evaluation.

Authors:  Hugo Olvera-Vargas; Sébastien Leroy; Michael Rivard; Nihal Oturan; Mehmet Oturan; Didier Buisson
Journal:  Environ Sci Pollut Res Int       Date:  2016-08-25       Impact factor: 4.223

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.